13F

Stock

Sarepta Therapeutics, Inc.

SRPT · held by 5 managers

Reported value

$88.6M

Holders

5

+1 new · −0 exited

Holders’ est. mark

−$42.6M

Price effect on 4 books still in the name

Largest holder

$69.4M

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC5.09M$69.4M−$44.6MAdded$19.5M
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main13.4M$17.3M$1.66MCut−$1.26M
DANSKE BANK A/S12K$1.9M$342.7KCut−$1.03M
Leonteq Securities AG4$632$114Cut−$94.9K

Positions as of Q2 2024. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.